Gambaran Umum
Ang Cizzle Biotechnology Holdings Plc ay isang kumpanyang nakabase sa UK na tumatakbo sa sektor ng biotechnology. Pangunahing nakatuon ang kumpanya sa pagbuo ng mga diagnostic at therapeutic intervention para sa lung cancer, bukod sa iba pang uri ng cancer. Kasama sa isang pangunahing proyekto ang kanilang pakikipagtulungan upang isulong ang pagbuo ng isang pagsusuri sa dugo na nilayon para sa maagang pagtuklas ng kanser sa baga, na batay sa isang nobelang biomarker na natuklasan sa Unibersidad ng York. Ang biomarker na ito, CIZ1B, ay gumaganap ng isang mahalagang papel sa pagkilala sa pagitan ng benign at malignant na mga nodul sa baga sa mga pasyente. Ang kumpanya ay nakatuon sa pagpapahusay ng pagtuklas ng kanser at mga paraan ng paggamot, nagsusumikap na tulay ang agwat sa pagitan ng maagang yugto ng pagtuklas at matagumpay na resulta ng therapy sa kanser. Ang inisyatiba na ito ay sumasalamin sa pangako ng Cizzle Biotechnology Holdings Plc sa mga makabagong solusyon sa pangangalagang pangkalusugan at epektibong pamamahala sa pag-unlad ng kanser sa baga.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Cizzle Biotechnology Holdings Plc per 2024 Dec 31 adalah -0.88 MM.
- Nilai net income untuk Cizzle Biotechnology Holdings Plc per 2024 Dec 31 adalah -2.17 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2024-12-31 | -0.88 | -2.17 | |
2024-09-30 | -0.90 | -2.43 | |
2024-06-30 | -0.93 | -2.70 | |
2024-03-31 | -0.95 | -2.21 | |
2023-12-31 | -0.98 | -1.72 | |
2023-09-30 | -0.97 | -1.33 | |
2023-06-30 | -0.96 | -0.95 | |
2023-03-31 | -0.96 | -0.93 | |
2022-12-31 | -0.96 | -0.91 | |
2022-09-30 | -1.02 | -0.99 | |
2022-06-30 | -1.08 | -1.07 | |
2022-03-31 | -0.96 | -2.50 | |
2021-12-31 | -0.85 | -3.92 | |
2021-09-30 | -0.49 | -3.58 | |
2021-06-30 | -0.12 | -3.24 | |
2021-03-31 | -0.07 | -1.63 | |
2020-12-31 | -0.01 | -0.01 | |
2020-09-30 | -0.01 | -0.03 | -0.03 |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | -0.01 | -0.01 |
2024-03-31 | -0.01 | -0.01 |
2023-12-31 | -0.00 | |
2023-09-30 | -0.00 | -0.00 |
2023-06-30 | -0.00 | -0.00 |
2023-03-31 | -0.00 | -0.00 |
2022-12-31 | -0.00 | |
2022-09-30 | -0.00 | -0.00 |
2022-06-30 | -0.00 | -0.00 |
2022-03-31 | -0.01 | -0.01 |
2021-12-31 | -0.02 | |
2021-09-30 | -0.01 | -0.01 |
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | -0.03 | |
2020-09-30 | ||
2020-06-30 | -0.00 | -0.00 |
2020-03-31 | -0.00 | -0.00 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Cizzle Biotechnology Holdings Plc per 2024 Dec 31 adalah -0.36 MM.
- Nilai kas dari aktivitas pendanaan untuk Cizzle Biotechnology Holdings Plc per 2024 Dec 31 adalah 0.58 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2024-12-31 | -0.36 | 0.58 | |
2024-09-30 | -0.45 | 0.58 | |
2024-06-30 | -0.55 | 0.58 | |
2024-03-31 | -0.59 | 0.44 | |
2023-12-31 | -0.64 | 0.30 | |
2023-09-30 | -0.70 | -0.06 | 0.60 |
2023-06-30 | -0.77 | -0.12 | 0.90 |
2023-03-31 | -0.82 | -0.12 | 0.74 |
2022-12-31 | -0.87 | -0.12 | 0.59 |
2022-09-30 | -0.86 | -0.16 | 0.33 |
2022-06-30 | -0.85 | -0.20 | 0.07 |
2022-03-31 | -0.93 | -0.18 | 1.05 |
2021-12-31 | -1.01 | -0.15 | 2.03 |
2021-09-30 | -0.81 | -0.05 | 2.00 |
2021-06-30 | -0.60 | 0.05 | 1.97 |
2021-03-31 | -0.31 | 0.02 | 0.99 |
2020-12-31 | -0.02 | 0.01 | |
2020-09-30 | -0.02 | 0.01 | |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | 0.00 | -0.04 |
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Efektivitas Manajemen
- roa untuk Cizzle Biotechnology Holdings Plc pada 2024 Dec 31 adalah -1.59.
- roe untuk Cizzle Biotechnology Holdings Plc pada 2024 Dec 31 adalah -1.44.
- roic untuk Cizzle Biotechnology Holdings Plc pada 2024 Dec 31 adalah -3.40.
- croic untuk Cizzle Biotechnology Holdings Plc pada 2024 Dec 31 adalah 0.04.
- ocroic untuk Cizzle Biotechnology Holdings Plc pada 2024 Dec 31 adalah -0.69.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2024-12-31 | -1.59 | -1.44 | -3.40 | 0.04 | -0.69 |
2024-09-30 | -1.44 | -1.61 | |||
2024-06-30 | -0.62 | -0.84 | -1.14 | -0.22 | -0.42 |
2024-03-31 | |||||
2023-12-31 | -0.48 | -0.51 | -0.51 | -0.06 | -0.27 |
2023-09-30 | -0.36 | -0.38 | -0.36 | 0.00 | -0.29 |
2023-06-30 | -0.35 | -0.38 | -0.36 | 0.00 | -0.29 |
2023-03-31 | 0.00 | 0.00 | -0.07 | ||
2022-12-31 | -0.93 | -1.06 | -0.38 | -0.26 | -0.33 |
2022-09-30 | -1.06 | -0.38 | -0.26 | -0.33 | |
2022-06-30 | -2.57 | -0.81 | -0.43 | -0.39 | -0.34 |
2022-03-31 | 0.00 | 0.00 | 0.00 | ||
2021-12-31 | -4.18 | 0.93 | 0.00 | ||
2021-09-30 | 0.00 | 0.00 | |||
2021-06-30 | -293.95 | -2.44 | 1.06 | -0.45 | |
2021-03-31 | -147.61 | -1.22 | 0.53 | -0.23 | |
2020-12-31 | |||||
2020-09-30 | -1.91 | -4.73 | -15.70 | -6.89 | 0.00 |
2020-06-30 | -2.02 | -1.71 | |||
2020-03-31 | -1.46 | -10.51 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | 1.00 | 2.51 | 2.51 |
2020-06-30 | |||
2020-03-31 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |